In our study, we identified LPAR5+ macrophages that were present in the tumor tissue, and higher expression predicted a better prognosis, which would provide a new insight into prognosis assessment and immunotherapy of osteosarcoma. The gene discussed is LPAR5; the disease is neoplasm.